Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
35.36
-1.00 (-2.75%)
At close: Sep 4, 2026, 4:00 PM EDT
35.28
-0.08 (-0.23%)
After-hours: Sep 4, 2026, 7:51 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.22 billion as of September 4, 2026. Its market cap has increased by 391.04% in one year.
Market Cap
2.22B
Enterprise Value
2.14B
1-Year Change
391.04%
Ranking
Category
Stock Price
$35.36
ChartMarket Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.22B, an increase of 520.16%. That is a compound annual growth rate of 25.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.22B | 28.00% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 2.37B |
| Ocular Therapeutix | 2.34B |
| Palvella Therapeutics | 2.27B |
| Mesoblast | 2.23B |
| Rapport Therapeutics | 2.20B |
| UroGen Pharma | 2.16B |
| ADMA Biologics | 2.15B |
| Zenas BioPharma | 2.14B |